Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Hemoporfin
Locations
7
China
The 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Affiliated Hospital of Hebei Medical College of traditional Chinese Medicine
Shijiazhuang, Herbei, China
Wuxi People's Hospital
Wuxi, Jiangsu, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Peking University First Hospital
Beijing, China
PLA Army General Hospital
Beijing, China
Start Date
August 31, 2017
Primary Completion Date
April 19, 2023
Completion Date
April 19, 2023
Last Updated
December 20, 2023
NCT05171894
NCT04336163
NCT05771311
NCT00540917
NCT01924273
NCT00667472
Lead Sponsor
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions